[1]
Musti, K. et al. 2023. Possible Guidelines and Regulatory Issues on Biosimilars in INDIA, USA, EU. World Journal of Pharmacy and Biotechnology. 10, 02 (Oct. 2023), 51–56. DOI:https://doi.org/10.30904/j.wjpbt.2023.4601.